Methylene blue given during leg amputation surgery
Treatments studied
Part of Pain clinical trials.
This trial studies whether infusing methylene blue during above- or below-knee leg amputation can improve outcomes for people with poor blood flow to the legs. It targets patients having surgery under general anesthesia, while excluding those with certain allergies or blood clotting problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have poor blood flow in one or both lower legs from a vascular problem
- You are scheduled for an above-knee or below-knee amputation
- Your surgery will be done under general anesthesia (you are fully asleep)
- You do not have a history of allergy to local anesthetics
- You do not have a history of allergy to methylene blue
- You are not taking blood thinners (anticoagulants) and you do not have a clotting disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding methylene blue to the standard numbing medicine (ropivacaine) can reduce pain after hemorrhoid removal. If you are having a specific type of hemorrhoid surgery (Milligan-Morgan) and are otherwise healthy, this might help you recover with less discomfort.
This trial tests adding a medicine called dexmedetomidine to the numbing IV used during knee surgery. It aims to see if it provides better pain relief after surgery under spinal anesthesia.
This study compares two medications (dexmedetomidine and fentanyl) mixed with a numbing agent to see which works better for blocking pain during above-knee amputation surgery in patients with serious heart or lung disease. Both drugs are already used in anesthesia, and this trial tests which combination is safest and most effective for you.
This study tests if using a blue dye called methylene blue during knee replacement surgery can help doctors see and clean out infections better. It may help people having a first-time knee replacement or those with an infected knee replacement.
This trial tests if adding different amounts of methylene blue to a standard numbing medicine (ropivacaine) can improve pain relief, thinking ability, and hip movement after hip replacement surgery.
This trial looks at different anesthesia methods used during below-ankle amputations to see which works best. It may help guide better care for patients needing this surgery.
Hear when a new Methylene Blue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.